Phreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of “Buy” by Analysts

Phreesia, Inc. (NYSE:PHR) has earned an average rating of “Buy” from the thirteen ratings firms that are covering the company, MarketBeat.com reports. Twelve analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $34.0769.

Several research firms have weighed in on PHR. Wall Street Zen upgraded Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. DA Davidson upgraded Phreesia to a “strong-buy” rating in a report on Monday, September 8th. Needham & Company LLC raised their target price on Phreesia from $29.00 to $35.00 and gave the company a “buy” rating in a report on Friday, September 5th. Canaccord Genuity Group raised their target price on Phreesia from $34.00 to $38.00 and gave the company a “buy” rating in a report on Friday, September 5th. Finally, JMP Securities raised their target price on Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a report on Monday, September 8th.

Insiders Place Their Bets

In other news, SVP David Linetsky sold 23,729 shares of Phreesia stock in a transaction dated Friday, June 27th. The stock was sold at an average price of $28.50, for a total value of $676,276.50. Following the transaction, the senior vice president directly owned 193,510 shares in the company, valued at approximately $5,515,035. The trade was a 10.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Mark Douglas Smith sold 7,000 shares of Phreesia stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $29.00, for a total value of $203,000.00. Following the completion of the transaction, the director owned 37,353 shares in the company, valued at $1,083,237. The trade was a 15.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 128,343 shares of company stock valued at $3,739,343 in the last ninety days. Company insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Squarepoint Ops LLC increased its stake in Phreesia by 243.6% during the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after acquiring an additional 71,553 shares during the period. Tower Research Capital LLC TRC increased its stake in Phreesia by 332.5% during the second quarter. Tower Research Capital LLC TRC now owns 5,610 shares of the company’s stock valued at $160,000 after acquiring an additional 4,313 shares during the period. State of Tennessee Department of Treasury bought a new position in Phreesia during the second quarter valued at about $330,000. BNP Paribas Financial Markets increased its stake in Phreesia by 128.2% during the second quarter. BNP Paribas Financial Markets now owns 12,284 shares of the company’s stock valued at $350,000 after acquiring an additional 6,902 shares during the period. Finally, Brevan Howard Capital Management LP increased its stake in Phreesia by 184.2% during the second quarter. Brevan Howard Capital Management LP now owns 31,418 shares of the company’s stock valued at $894,000 after acquiring an additional 20,363 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Price Performance

PHR opened at $24.74 on Tuesday. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of -58.90 and a beta of 0.72. Phreesia has a 1 year low of $17.07 and a 1 year high of $32.76. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average price of $27.51 and a 200 day moving average price of $26.40.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.08. The firm had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The business’s revenue for the quarter was up 14.9% on a year-over-year basis. During the same quarter last year, the firm earned ($0.03) earnings per share. Phreesia has set its FY 2026 guidance at EPS. Analysts forecast that Phreesia will post -1.1 EPS for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.